Navigation Links
Photophobia in Medical News

MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints

... 33.8 percent for placebo (p<0.0001); photophobia free: 46.6 percent of patients who received ... include pain relief, and being phonophobia, photophobia and nausea free at two hours after dosing. ... include recurrent headaches, nausea, vomiting, photophobia (sensitivity to light) and phonophobia ...

MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine

... endpoints will be pain relief at two hours, and freedom from nausea, photophobia and phonophobia at two hours. About MAP0004 MAP0004 is a proprietary ... 24 hours. The study also demonstrated efficacy trends in treating nausea, photophobia and phonophobia. Based on these results, as well as independent research ...

Raptor Pharmaceuticals Corp. to Present at 2009 Cystinosis Research Network Family Conference

... to treat cystinosis can cause serious health consequences, including renal failure (and resultant kidney transplant), growth failure, rickets, photophobia and blindness. Cystinosis is typically treated with an immediate-release form of cysteamine bitartrate, which is currently the only therapeutic ...

MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results

... at 24 hours in a treatment received population. The trial also showed clinically significant trends in the resolution of phonophobia, photophobia and nausea at certain time points. MAP0004 was shown in the trial to be well tolerated and no serious adverse events were reported. -- ...

ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)

... Drug Administration (FDA) for Xibrom(TM) QD (once-daily). The Company is seeking approval for Xibrom QD as a treatment for inflammation, pain, and photophobia following cataract surgery. Xibrom(TM) (bromfenac ophthalmic solution) Xibrom is a topical non-steroidal anti-inflammatory compound for ...

Combination Therapy More Effective Than Monotherapy for Treating Migraine

... than placebo for headache relief at two hours after dosing (study 1, 65 percent vs. 28 percent; and study 2, 57 percent vs. 29 percent;), absence of photophobia (sensitivity to light) at two hours (58 percent vs. 26 percent; and 50 percent vs. 32 percent;), and absence of phonophobia (sensitivity to sound) at ...
Photophobia in Medical Technology

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

... 24 hours. The study also demonstrated efficacy trends in treating nausea, photophobia and phonophobia, the other key measurements in treating migraine. This ... primary efficacy endpoints will be pain relief, and freedom from nausea, photophobia and phonophobia as measured at two hours after dosing. MAP will also ...

TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache

... relief of migraine-associated symptoms such as nausea, vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to sound), as well as ... pain relief at two hours, pain-free at two hours and relief of nausea, photophobia and phonophobia. About AK Receptor Antagonists AMPA/kainate (AK) ...

ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%

... efficacy. In addition, both Phase III studies showed highly statistically significant results in the proportion of subjects with no photophobia (light sensitivity) at every study visit post-cataract surgery. This is in concordance with previous clinical trials with Xibrom. The studies also ...

Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented

... of the condition is anterior uveitis, associated primarily with inflammation of the iris. If left untreated, uveitis can cause debilitating pain and photophobia as well as permanent damage and vision loss due to the development of glaucoma, cataract or retinal edema. Dr. Kaufman's poster, "Data from Trials ...

MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

... relief in as fast as ten minutes, with relief sustained through at least 24 hours. The study also demonstrated efficacy trends in treating nausea, photophobia and phonophobia, the other key measurements in treating migraine. The therapeutic agent in MAP0004 is dihydroergotamine (DHE), which has a long ...

MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting

... ten minutes of dosing, and this relief was sustained through at least 24 hours. The study also demonstrated efficacy trends in treating nausea, photophobia and phonophobia. Based on these results, as well as independent research that concludes that patients prefer migraine therapies providing fast ...

TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel

... traditionally required for regulatory approval. These endpoints included pain relief at two hours, pain-free at two hours and relief of nausea, photophobia and phonophobia. About AK Receptor Antagonists AK receptors are part of the glutamate biological pathway that transmits pain signals to the brain. ...

Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA

... versus placebo on the following variables: -- Headache relief -- Absence of phonophobia (sensitivity to sound) -- Absence of photophobia (sensitivity to light) -- Absence of nausea The second objective was to assess the sustained effect of Trexima from two through 24 hours ...
Photophobia in Medical Definition

Pathology

... Aniseikonia Visual disturbances and blindness Amblyopia - Leber's congenital amaurosis - Subjective ( Asthenopia , Hemeralopia , photophobia , Scintillating scotoma ) - Diplopia - Scotoma - Anopsia ( Binasal hemianopsia , Bitemporal hemianopsia , Homonymous hemianopsia , ...
Photophobia in Medical Dictionary

Photophobia

... photophobia : Painful oversensitivity to light. For example, there is photophobia in measles ( rubeola ). Keeping the lights dim ... may be useful. Sunglasses may also help. photophobia ; Light sensitivity; Light hurts the eyes ; ...

Eye pain

... Guide > Eye Pain Eye Pain - ... Eye pain . Sensitivity to light ( photophobia ). Decreased vision in all or part of the vision field. Blurred ... there a fever ? Is there a stiff neck? Are the eyes light-sensitive ( photophobia )? Is there eye pain ? Is there loss of vision ? ...

Nystagmus

... sign of the syndrome in infancy is often extreme light sensitivity ( photophobia ) and a wobbling of the eyes ( nystagmus ). From 4 to 10% of ... nystagmus (recurrent flickering back-and-forth eye movements ), photophobia , amaurosis, color blindness , ... Nystagmus (rhythmic jerking ...

Eye movements

... Los Angeles, CA. Review provided by VeriMed Healthcare Network. Rapid eye movements ( nystagmus ) Strabismus ( eyes not tracking properly) photophobia (avoidance of light because of discomfort) Decreased visual acuity or even functional blindness ... The involuntary eye movements of ...

Tearing

... syndrome . But these are called irritant tears, and are produced as a reflex reaction to the syndrome . excessive tearing light sensitivity ( photophobia ) closure of one or both eyes in the light cloudy, enlarged cornea one eye may be larger than the other vision loss ... - Tearing - ...
Photophobia in Biological Technology

Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA

... damage and vision loss due to the development of glaucoma, cataract, or retinal edema. In addition to potential vision loss, the severe pain and photophobia that accompany anterior uveitis can be debilitating. About Durezol Durezol (difluprednate ophthalmic emulsion) 0.05% is a topical ...

MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine

... safety and efficacy of MAP0004 as a potential acute treatment for migraine. The primary efficacy endpoints are pain relief and freedom from nausea, photophobia and phonophobia as measured at two hours after dosing. The study is also evaluating earliest onset of pain relief, pain relief at 10 minutes, ...

Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008

... Failure to treat the disease can cause serious health consequences, including renal failure and resultant kidney transplant, growth failure, rickets, photophobia and blindness. In collaboration with the University of California, San Diego ("UCSD"), supported by the Cystinosis Research Foundation ("CRF"), ...

ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results

... December of 2007 after announcing, earlier in the year, positive Phase III results for Xibrom QD as a treatment for inflammation, pain, and photophobia following cataract surgery -- Announced statistically significant Phase II/III study results for Bepreve in treating ocular itching and ...
Photophobia in Biological Definition

Albinism

... that often come with age, the gain is generally thought be out-weighed by the trauma. The lack of pigment in the eye generally leads to ocular photophobia or hyper-photo-sensitivity . This is due not so much by the iris allowing stray light into enter the eye, as to a lack of pigment within the eye, ...
Other Contents
(Date:10/30/2014)... research group at the DFG Research Center for Regenerative ... Dresden (CRTD) demonstrated for the first time the in ... three dimensions from mouse embryonic stem cells. Correct spatial ... the dorsal/ventral axis was observed., This study has been ... Cell Reports " on 30.10.2014 ., For many years ...
(Date:10/30/2014)... NC (PRWEB) October 30, 2014 Don ... commercial, and health insurance plans for North Carolina residents, ... satellite office in Burlington’s Holly Hill Mall. The new ... with agents already helping customers through all facets of ... purchase. , Allred Insurance spokesman Scott Allred couldn’t be ...
(Date:10/30/2014)... Radio listeners who indicate use of ... impact of traditional radio commercials and have overwhelmingly endorsed ... influence a purchasing decision. , Those are some highlights ... by radio marketing company CRN International. The research is ... of respondents who indicated they have purchased or considered ...
(Date:10/30/2014)... Chicago, IL (PRWEB) October 30, 2014 Dr. ... launched a new website for his practices; OB GYN ... Chicago, IL . This website contains important information about ... covers as well as downloadable patient forms in English and ... use and the service pages on the website provide Dr. ...
(Date:10/30/2014)... Rock Hill, South Carolina (PRWEB) October 30, 2014 ... a muscle, and should be more vigorously exercised to ... Grewal. He recently authored the book ‘Dementia Express: Lose ... , The book uses counterintuitive reasoning and sometimes conflicting ... an obstacle course for the mind, a reader must ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Allred Insurance Satellite Office Grand Opening 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2
(Date:10/30/2014)... This news release is available in German . ... we as individuals prompt our fellow humans to behave ... to social dilemmas in game theory. Previous studies assumed ... large groups. Nonetheless, scientists from the Max Planck Institute ... us can exert an influence on the cooperative behaviour ...
(Date:10/30/2014)... 29, 2014  Securus Technologies, a leading ... solutions for public safety, investigation, corrections and ... exciting enhancements to its THREADS™ product, which ... actionable intelligence and focused leads for investigators. ... technological innovation through identifying and delivering solutions ...
(Date:10/29/2014)... Online registration is open for the ... Scientific Meeting. SIR 2015 is the one ... trainees and related health care professionals can ... image-guided science and technologies being presented, discussed ... community in minimally invasive, image-guided medicine, SIR ...
Breaking Biology News(10 mins):Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2SIR 2015: Interventional radiology shapes tomorrow's medicine 2
Other TagsOther Tags